BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
under private label as front-end system solutions and through OEM
partnering as customized system components.
Our organization will operate with mutual trust and respect to our customers,
suppliers, employees, shareholders and other parties. Honesty and the right
values will be the basis for our activities. We want to create excellent
shareholder value and achieve sustainable growth by investing in research
and development. We will nurture innovation and continue to look for ways
to improve our products and services.
RESEARCH & DEVELOPMENT: Develop and manufacture automatic sample handling and sample
preparation systems for LC and LC MS
PRODUCTS ON MARKET: Symbiosis system ( automated sample preparation system)
Mistral column oven
Triathlon Endurance autosampler
Midas autosampler
Reliance autosampler
Basic Marathon autosampler
Spherix Inc.
12051 Indian Creek Court
Beltsville MD 20705, US
Phone: (301) 419-3900; Fax: (301) 210-4908
Web: www.spherix.com
E-mail: info@spherix.com
KEY PERSONNEL: Dr. Gilbert V. Levin; Chairman and Exec. Officer for Science
Richard C. Levin; CEO and President
Roger A. Downs; VP, Operations
Steven M. Wade; VP, Information Technology
Jeffrey T. Lowe; VP, Corporate Communications
Katherine M. Brailer; Corporate Secretary
EMPLOYEES: 750 employees
HISTORY: Founded in 1967
Sold Environmental & Laboratory Service Division to ManTech
Environmental Corp. (3/96)
FACILITIES: 95,000 sq. ft. office facility
12,700 sq. ft. regional office located in Cumberland, Md.
STOCK-FINANCIAL HISTORY: NASDAQ--SPEX
Two-for-one stock split (5/96)
Revenue $23.046M (YE 05) compared $22.348M (YE 04)
Net loss (YE 05) compared to (YE 04)
Loss per share (YE 05) compared to (YE 04)
SUBSIDIARIES/DIVISIONS: InfoSpherix Inc. (wholly-owned subsidiary)
BioSpherix Division
BUSINESS STRATEGY: Create value and increase the wealth of our shareholders through
innovations that benefit our clients and the human condition
AGREEMENTS: Name Products Content of Agreement Date
Albert Einstein certain medicinal uses licensing agreement 11/05
College of
Medicine
of Naturlose
GleneaglesCRC Naturlose for the GleneaglesCRC to 5/06
treatment for Type II conduct Phase IIII
diabetes
trials
MD Foods
Ingredients amba
(Denmark)
D-tagatose licensing agreement 1/97
Copyright ©2006 AHC Media ® 353